Biotech · Private company
Valerio Therapeutics
Track this companyFree. Adds Valerio Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Doxorubicin 20 mg/m2Phase 3 · Carcinoma, HepatocellularClinicalTrials.gov · fetched Nov 12, 2026
- Doxorubicin 30 mg/m2Phase 3 · Carcinoma, HepatocellularClinicalTrials.gov · fetched Nov 12, 2026
- AsiDNAPhase 2 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- OlaparibPhase 2 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- VIO-01Phase 2 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jan 10, 2024ClinicalTrials.gov NCT06257758 · fetched Nov 12, 2026
- Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid TumorsPHASE1_PHASE2 · COMPLETED · started Feb 20, 2023ClinicalTrials.gov NCT05700669 · fetched Nov 12, 2026
- Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular CarcinomaPHASE3 · COMPLETED · started Jun 1, 2012ClinicalTrials.gov NCT01655693 · fetched Nov 12, 2026
- MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLCPHASE1_PHASE2 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01310244 · fetched Nov 12, 2026
- Belinostat in Relapsed or Refractory Peripheral T-Cell LymphomaPHASE2 · COMPLETED · started Dec 15, 2008ClinicalTrials.gov NCT00865969 · fetched Nov 12, 2026